Researchers Unveil tPAL Nanopore Method for 1-Amino-Acid Peptide Sequencing
Updated
Updated · Nature.com · Jul 29
Researchers Unveil tPAL Nanopore Method for 1-Amino-Acid Peptide Sequencing
1 articles · Updated · Nature.com · Jul 29
Summary
Nature published a nanopore peptide-sequencing strategy called transient pore analyte looping, or tPAL, that reads immobilized peptides one amino acid at a time with single-amino-acid resolution.
An engineered MspA nanopore repeatedly rereads the peptide’s N terminus, while a cholesterolized aminopeptidase trims the chain in 1-amino-acid steps, producing narrow, sequence-dependent signal shifts for decoding.
27 signal features gathered across 3 voltages fed a machine-learning decoder that reached 98.0% validation accuracy in classifying peptide variants in the study’s benchmark tests.
The method also distinguished single-amino-acid mutations, post-translational modifications such as methionine oxidation and lysine acetylation, and unnatural-amino-acid insertions.
The authors say the approach could broaden single-molecule proteomics beyond mass spectrometry, though the paper frames it as a platform advance rather than a ready commercial sequencing system.
If enzymes trim peptides one by one, can this method truly scale fast enough to decode an entire human proteome?
Will the ability to sequence rare chiral and modified peptides spark a new era of undiscovered, hyper-targeted therapeutics?
98% Accuracy in Single-Molecule Protein Sequencing: How tPAL Nanopore Technology Is Transforming Proteomics and Diagnostics
Overview
The tPAL nanopore method, introduced in 2026, marks a major advance in single-molecule protein sequencing by overcoming the challenges posed by proteins’ complex shapes and diverse charges. Using engineered nanopores and machine learning, tPAL achieves high accuracy in identifying amino acids and their modifications. This technology enables repeated scanning to reduce errors and is now affordable enough for decentralized clinical use. However, physical limits on nanopore size restrict the length of peptides that can be analyzed, and highly charged or long peptides remain difficult to sequence. As personalized medicine expands, ethical concerns about data privacy and discrimination become increasingly important.